Comprehensive Hepatology Care
Chronic liver disease management requires ongoing monitoring, treatment of underlying causes, prevention of complications, and surveillance for hepatocellular carcinoma. Our approach emphasises early intervention and comprehensive care.
Viral Hepatitis Management
Hepatitis B: Antiviral therapy selection based on viral load, HBeAg status, and liver fibrosis assessment. Regular monitoring ensures optimal treatment response and adjustment.
Hepatitis C: Direct-acting antiviral (DAA) therapy provides cure rates exceeding 95%. Treatment selection considers genotype, previous treatment history, and potential drug interactions.
Non-Alcoholic Fatty Liver Disease (NAFLD)
Comprehensive lifestyle intervention forms the cornerstone of NAFLD management, combined with treatment of metabolic comorbidities. Regular monitoring assesses disease progression and development of complications.
Autoimmune Liver Diseases
Management of autoimmune hepatitis, primary biliary cholangitis, and primary sclerosing cholangitis requires immunosuppressive therapy, monitoring for complications, and symptom management.
Complication Management
- Portal hypertension and varices surveillance
- Ascites management and infection prevention
- Hepatic encephalopathy treatment
- Nutritional support and bone health maintenance
Surveillance Protocols
Regular hepatocellular carcinoma surveillance using ultrasound and AFP measurement, with appropriate intervals based on risk factors and liver disease aetiology.
